dronabinol has been researched along with Schizotypal Personality Disorder in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Curran, HV; Freeman, AM; Freeman, TP; Hindocha, C; Lawn, W; Mokrysz, C; Morgan, CJ; Saunders, R | 1 |
| Curran, HV; Das, RK; Freeman, TP; Gardener, C; Hindocha, C; Morgan, CJ; Schafer, G | 1 |
| van Winkel, R | 1 |
| Curran, HV; Demarchi, C; Freeman, TP; Gardener, C; Lewis, S; Morgan, CJ; Ramoutar, A; Rupasinghe, I; Schafer, G; Swan, S; Tan, N; Warrington, P; Wingham, G | 1 |
1 review(s) available for dronabinol and Schizotypal Personality Disorder
| Article | Year |
|---|---|
Does variation in trait schizotypy and frequency of cannabis use influence the acute subjective, cognitive and psychotomimetic effects of delta-9-tetrahydrocannabinol? A mega-analysis.
Topics: Adult; Cannabinoid Receptor Agonists; Dronabinol; Drug Tolerance; Female; Humans; Male; Marijuana Use; Schizotypal Personality Disorder; Young Adult | 2021 |
1 trial(s) available for dronabinol and Schizotypal Personality Disorder
| Article | Year |
|---|---|
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users.
Topics: Administration, Inhalation; Cannabidiol; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Combinations; Drug Interactions; Emotions; Facial Recognition; Female; Humans; Longitudinal Studies; Male; Marijuana Smoking; Photic Stimulation; Psychotropic Drugs; Schizotypal Personality Disorder; Surveys and Questionnaires; Visual Analog Scale; Young Adult | 2015 |
3 other study(ies) available for dronabinol and Schizotypal Personality Disorder
| Article | Year |
|---|---|
Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: an analysis of patient-sibling and sibling-control pairs.
Topics: Adolescent; Adult; Belgium; Case-Control Studies; Comorbidity; Cross-Sectional Studies; Dronabinol; Female; Genetic Predisposition to Disease; Humans; Male; Marijuana Abuse; Middle Aged; Netherlands; Phenotype; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Psychotic Disorders; Risk Assessment; Schizotypal Personality Disorder; Siblings; Young Adult | 2011 |
Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: sibling analysis and proband follow-up.
Topics: Adolescent; Adult; Belgium; Case-Control Studies; Dronabinol; Female; Follow-Up Studies; Gene Expression Regulation; Genetic Association Studies; Genetic Predisposition to Disease; Genetic Variation; Genotype; Humans; Male; Marijuana Abuse; Middle Aged; Netherlands; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Risk Factors; Schizotypal Personality Disorder; Siblings; Young Adult | 2011 |
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being.
Topics: Adolescent; Adult; Anxiety; Cannabidiol; Cognition Disorders; Depression; Dronabinol; Female; Hair; Humans; Illicit Drugs; Male; Marijuana Smoking; Memory; Psychoses, Substance-Induced; Schizotypal Personality Disorder; Young Adult | 2012 |